Safety and efficacy of transcatheter embolization for pulmonary arteriovenous fistula: a 21-year retrospective study - Summary - MDSpire

Safety and efficacy of transcatheter embolization for pulmonary arteriovenous fistula: a 21-year retrospective study

  • By

  • Hong Lu

  • Jianming Wang

  • Jiawang Xiao

  • Zhongchao Wang

  • Hui Yao

  • Benshen Li

  • Yuan Mi

  • Qiguang Wang

  • May 29, 2026

  • 0 min

Share

Objective:

To evaluate the safety and efficacy of transcatheter embolization (TCE) for pulmonary arteriovenous fistula (PAVF).

Key Findings:
  • Procedural success rate was 100%, with an immediate complete occlusion rate of 87.8%.
  • Postoperative SaO2 significantly increased from 84.1% to 92.0% (P < 0.001).
  • Two patients (7.14%) developed fever and one patient (3.57%) developed pleural effusion.
  • Reperfusion occurred in 1 case (14.29%) of the ADO II group; no reperfusion in other groups (P = 0.463, not statistically significant).
Interpretation:

Limitations:
  • Study limited to a single center with a small sample size.
  • Follow-up duration varied significantly among patients.
Conclusion:

TCE for PAVFs demonstrates high procedural success rates.

Original Source(s)

Safety and efficacy of transcatheter embolization for pulmonary arteriovenous fistula: a 21-year retrospective study

  • by Hong Lu, Jianming Wang, Jiawang Xiao, Zhongchao Wang, Hui Yao, Benshen Li, Yuan Mi, Qiguang Wang

  • May 29, 2026

Related Content

Sleep, circadian rhythms and outcomes in intensive care unit

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.

FDA Expands Afrezza to Pediatric Diabetes

The decision was supported by the phase 3 INHALE-1 trial and additional long-term safety, efficacy, and exposure data.